RNA Targeting Small Molecule Drug Discovery Global Market Report 2024

Description

RNA targeting small-molecule drug discovery involves the identification and development of small-molecule drugs designed to interact with RNA molecules, influencing their function or activity. This approach is employed to uncover novel medications for the treatment of diverse diseases, including genetic disorders, viral infections, neurodegenerative conditions, and cancer.

The primary RNA types in the realm of RNA targeting small-molecule drug discovery, are messenger RNA (mRNA), non-coding RNA (ncRNA), microRNA (miRNA), and long non-coding RNA (lncRNA). Messenger RNA (mRNA) serves as the carrier of genetic information from the DNA in the cell's nucleus to the ribosomes, where protein synthesis takes place. Various technologies, such as CRISPR-cas9, RNA aptamers, small interfering RNA (siRNA), ribozymes, and others, are employed across multiple therapeutic areas, including oncology, neurology, infectious diseases, metabolic disorders, genetic conditions, and more. Delivery methods encompass intravenous (IV), oral, topical, and others, with applications in research, therapeutics, diagnostics, and various other uses.

The RNA targeting small molecule drug discovery market research report is one of a series of new reports from The Business Research Company that provides RNA targeting small molecule drug discovery market statistics, including RNA targeting small molecule drug discovery industry global market size, regional shares, competitors with an RNA targeting small molecule drug discovery market share, detailed RNA targeting small molecule drug discovery market segments, market trends, and opportunities, and any further data you may need to thrive in the RNA targeting small molecule drug discovery industry. This RNA-targeting small molecule drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rna targeting small molecule drug discovery market size has grown exponentially in recent years. It will grow from $1.45 billion in 2023 to $1.78 billion in 2024 at a compound annual growth rate (CAGR) of 22.3%. The growth observed in the historical period can be ascribed to a heightened comprehension of disease genetics, discoveries in genomics and proteomics, challenges related to drug resistance, substantial investments in biotechnology and pharmaceutical research, and the emergence of RNA therapeutics.

The rna targeting small molecule drug discovery market size is expected to see exponential growth in the next few years. It will grow to $3.97 billion in 2028 at a compound annual growth rate (CAGR) of 22.2%. The anticipated growth in the forecast period can be linked to the expansion of research in RNA epigenetics, advancements in RNA-seq and functional genomics, the incorporation of artificial intelligence (AI), patient-centric approaches, and the utilization of exosome-mediated drug delivery. Notable trends expected in the forecast period encompass the emergence of RNA editing technologies, progress in CRISPR technology, technological innovations, advancements in RNA biology, and the exploration of RNA targeting in neurodegenerative diseases.

The anticipated growth in the RNA-targeted small-molecule drug discovery market is driven by the increasing prevalence of cancer, genetic disorders, and viral infections. Cancer, characterized by uncontrolled cell growth, and viral infections, caused by replicating viruses within living organisms, are targeted by RNA-based drug discovery due to their association with genetic abnormalities. For instance, the American Cancer Society projects a 47% increase in new cancer cases and deaths by 2040, totaling approximately 28.4 million cases. Additionally, in 2021, the World Health Organization reported around 38.4 million people living with HIV and 650,000 deaths attributed to HIV. This highlights the significance of RNA-targeted approaches in addressing such health challenges.

The growth of the RNA-targeted small-molecule drug discovery market is fueled by the rising interest in personalized medicine. Personalized medicine tailors medical decisions, interventions, and drug therapies to individual patients. In the context of RNA targeting, personalized medicines can offer higher specificity, minimizing off-target effects and catering to individual genetic variations. A report by STAT indicates over 75,000 genetic testing products and 300 personalized medicines in existence as of October 2022, underscoring the increasing emphasis on personalized approaches in healthcare. Hence, the surge in personalized medicine interest contributes to the expansion of the RNA-targeted small-molecule drug discovery market.

The integration of artificial intelligence (AI) into drug discovery processes is a prominent trend in the small-molecule drug discovery market. Major companies within the market are embracing AI technology to expedite drug discovery procedures and maintain their competitive positions. For example, in May 2023, Google Cloud, the cloud computing suite of the US-based technology company Google, introduced the Target and Lead Identification Suite and Multiomics Suite to streamline drug discovery. The Multiomics Suite facilitates the identification and analysis of genetic data, aiding in the design of precision medicines. The Target and Lead Identification Suite supports researchers in comprehending the role of amino acids and predicting protein structures.

Companies in the RNA-targeting small-molecule drug discovery market are innovating by developing platforms such as software-as-a-service (SaaS) to enhance their competitiveness. SaaS is a software distribution model where applications are hosted by a third-party provider and made accessible to customers over the internet. In December 2023, Merck & Co. Inc., a US-based science and technology company, launched AIDDISON, a platform that recommends optimal ways to synthesize selected medications. This AI-driven approach aims to bring significant cost savings to the drug discovery process and improve the success rate of introducing novel medicines. AIDDISON integrates computer-aided drug design, machine learning, and generative AI to accelerate medication development by extracting insights from large datasets.

In December 2021, Novo Nordisk, a Denmark-based pharmaceutical company, acquired Dicerna Pharmaceuticals for $3.3 billion. This acquisition incorporated Dicerna's ribonucleic acid interference (RNAi) platform into Novo's research tools, enhancing their capabilities in RNA-based drug discovery for the development of novel therapeutics. Dicerna Pharmaceuticals, based in the United States, has been actively involved in RNA-based drug discovery.

Major companies operating in the rna targeting small molecule drug discovery market report are F. Hoffmann-La Roche Ltd , Merck & Co. Inc, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk Inc., Moderna Inc., Astellas Pharma Inc., Biogen Inc., Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Evotec A.G., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Arrakis Therapeutics, Arbutus Biopharma Corporation, H3 Biomedicine Inc., Anima Biotech Inc., Ribometrix Inc., Quark Pharmaceuticals Inc., Regulus Therapeutics Inc., Skyhawk Therapeutics Inc., Accent Therapeutics Inc., Epics Therapeutics, Expansion Therapeutics

North America was the largest region in the RNA targeting small molecule drug discovery market in 2023. The regions covered in the rna targeting small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the rna targeting small molecule drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The RNA targeting small molecule drug discovery market consists of revenues earned by entities by providing hit identification, hit validation, and hit characterization. The market value includes the value of related goods sold by the service provider or included within the service offering. The RNA targeting small molecule drug discovery market also includes sales of asRNAs, and siRNAs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

RNA Targeting Small Molecule Drug Discovery Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rna targeting small molecule drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rna targeting small molecule drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rna targeting small molecule drug discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Target RNA Type: Messenger RNA (mRNA); Non-Coding RNA (ncRNA); MicroRNA (miRNA); Long Non-Coding RNA (lncRNA)
2) By Technology: CRISPR-Cas9; RNA Aptamers; Small Interfering RNA (siRNA); Ribozymes; Other Technologies
3) By Therapeutic Area: Oncology; Neurology; Infectious Disease; Metabolic Diseases; Genetic Disorders; Other Therapeutic Areas
4) By Delivery Method: Intravenous (IV); Oral; Topical; Other Methods
5) By Application: Research Use; Therapeutic Use; Diagnostic Use; Other Applications
Companies Mentioned: F. Hoffmann-La Roche Ltd. ; Merck & Co. Inc.; Bayer AG; Novartis AG; Sanofi SA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r14061

1. Executive Summary

2. RNA Targeting Small Molecule Drug Discovery Market Characteristics

3. RNA Targeting Small Molecule Drug Discovery Market Trends And Strategies

4. RNA Targeting Small Molecule Drug Discovery Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global RNA Targeting Small Molecule Drug Discovery Market Size and Growth

5.1. Global RNA Targeting Small Molecule Drug Discovery Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global RNA Targeting Small Molecule Drug Discovery Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global RNA Targeting Small Molecule Drug Discovery Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. RNA Targeting Small Molecule Drug Discovery Market Segmentation

6.1. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Messenger RNA (mRNA)
Non-Coding RNA (ncRNA)
MicroRNA (miRNA)
Long Non-Coding RNA (lnc RNA)
6.2. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
CRISPR-Cas9
RNA Aptamers
Small Interfering RNA (siRNA)
Ribozymes
Other Technologies
6.3. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oncology
Neurology
Infectious Disease
Metabolic Diseases
Genetic Disorders
Other Therapeutic Areas
6.4. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Delivery Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Intravenous (IV)
Oral
Topical
Other Methods
6.5. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Research Use
Therapeutic Use
Diagnostic Use
Other Applications

7. RNA Targeting Small Molecule Drug Discovery Market Regional And Country Analysis

7.1. Global RNA Targeting Small Molecule Drug Discovery Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global RNA Targeting Small Molecule Drug Discovery Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market

8.1. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China RNA Targeting Small Molecule Drug Discovery Market

9.1. China RNA Targeting Small Molecule Drug Discovery Market Overview
9.2. China RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India RNA Targeting Small Molecule Drug Discovery Market

10.1. India RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan RNA Targeting Small Molecule Drug Discovery Market

11.1. Japan RNA Targeting Small Molecule Drug Discovery Market Overview
11.2. Japan RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia RNA Targeting Small Molecule Drug Discovery Market

12.1. Australia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia RNA Targeting Small Molecule Drug Discovery Market

13.1. Indonesia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea RNA Targeting Small Molecule Drug Discovery Market

14.1. South Korea RNA Targeting Small Molecule Drug Discovery Market Overview
14.2. South Korea RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe RNA Targeting Small Molecule Drug Discovery Market

15.1. Western Europe RNA Targeting Small Molecule Drug Discovery Market Overview
15.2. Western Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK RNA Targeting Small Molecule Drug Discovery Market

16.1. UK RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany RNA Targeting Small Molecule Drug Discovery Market

17.1. Germany RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France RNA Targeting Small Molecule Drug Discovery Market

18.1. France RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy RNA Targeting Small Molecule Drug Discovery Market

19.1. Italy RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain RNA Targeting Small Molecule Drug Discovery Market

20.1. Spain RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market

21.1. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market Overview
21.2. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia RNA Targeting Small Molecule Drug Discovery Market

22.1. Russia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America RNA Targeting Small Molecule Drug Discovery Market

23.1. North America RNA Targeting Small Molecule Drug Discovery Market Overview
23.2. North America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA RNA Targeting Small Molecule Drug Discovery Market

24.1. USA RNA Targeting Small Molecule Drug Discovery Market Overview
24.2. USA RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada RNA Targeting Small Molecule Drug Discovery Market

25.1. Canada RNA Targeting Small Molecule Drug Discovery Market Overview
25.2. Canada RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America RNA Targeting Small Molecule Drug Discovery Market

26.1. South America RNA Targeting Small Molecule Drug Discovery Market Overview
26.2. South America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil RNA Targeting Small Molecule Drug Discovery Market

27.1. Brazil RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East RNA Targeting Small Molecule Drug Discovery Market

28.1. Middle East RNA Targeting Small Molecule Drug Discovery Market Overview
28.2. Middle East RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa RNA Targeting Small Molecule Drug Discovery Market

29.1. Africa RNA Targeting Small Molecule Drug Discovery Market Overview
29.2. Africa RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. RNA Targeting Small Molecule Drug Discovery Market Competitive Landscape And Company Profiles

30.1. RNA Targeting Small Molecule Drug Discovery Market Competitive Landscape
30.2. RNA Targeting Small Molecule Drug Discovery Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Merck & Co. Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Bayer AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Novartis AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Sanofi SA
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. RNA Targeting Small Molecule Drug Discovery Market Other Major And Innovative Companies

31.1. Bristol-Myers Squibb Company
31.2. AstraZeneca PLC
31.3. Takeda Pharmaceutical Company Limited
31.4. Eli Lilly and Company
31.5. Amgen Inc.
31.6. Novo Nordisk Inc.
31.7. Moderna Inc.
31.8. Astellas Pharma Inc.
31.9. Biogen Inc.
31.10. Alnylam Pharmaceuticals Inc.
31.11. Sarepta Therapeutics Inc.
31.12. Evotec A.G.
31.13. PTC Therapeutics Inc.
31.14. Ionis Pharmaceuticals Inc.
31.15. Dicerna Pharmaceuticals Inc.

32. Global RNA Targeting Small Molecule Drug Discovery Market Competitive Benchmarking

33. Global RNA Targeting Small Molecule Drug Discovery Market Competitive Dashboard

34. Key Mergers And Acquisitions In The RNA Targeting Small Molecule Drug Discovery Market

35. RNA Targeting Small Molecule Drug Discovery Market Future Outlook and Potential Analysis

35.1 RNA Targeting Small Molecule Drug Discovery Market In 2028 - Countries Offering Most New Opportunities
35.2 RNA Targeting Small Molecule Drug Discovery Market In 2028 - Segments Offering Most New Opportunities
35.3 RNA Targeting Small Molecule Drug Discovery Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer